The Oncosearch | Oncotarget

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy Research Paper

Caitlin D. Lowery, Wayne Blosser, Michele Dowless, Matthew Renschler, Lisa V. Perez, Jennifer Stephens, Bronislaw Pytowski, Heather Wasserstrom, Louis F. Stancato, Beverly Falcon

Published Sep 17, 2019 · Vol. 10, No. 53 · pp. 5523-5533

Keywords: angiogenesis, pediatric cancer, VEGFR2, ramucirumab, DC101

Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP Research Paper

Kazuhiro Kitajima, Masaya Okada, Kyoko Yoshihara, Tazuko Tokugawa, Akihiro Sawada, Satoshi Yoshihara, Hiroya Tamaki, Yoshihiro Fujimori, Syuji Ueda, Hiroyuki Kawamoto, Junichi Taniguchi, Koichiro Yamakado

Published Sep 10, 2019 · Vol. 10, No. 52 · pp. 5403-5411

Keywords: non-Hodgkin lymphoma, PET-CT, progression-free survival

Application of C. elegans cancer screening test for the detection of pancreatic tumor in genetically engineered mice Research Paper

Yuji Ueda, Koichi Kawamoto, Masamitsu Konno, Kozo Noguchi, Satoru Kaifuchi, Taroh Satoh, Hidetoshi Eguchi, Yuichiro Doki, Takaaki Hirotsu, Masaki Mori, Hideshi Ishii

Published Sep 10, 2019 · Vol. 10, No. 52 · pp. 5412-5418

Keywords: early detection, pancreatic cancer, C. elegans, genetically-engineered mice

SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells Research Paper

Ming-Bo Huang, Jennifer Y. Wu, James Lillard, Vincent C. Bond

Published Sep 10, 2019 · Vol. 10, No. 52 · pp. 5419-5438

Keywords: extracellular vesicles, mortalin, complement, SMR peptides, breast cancer

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma Research Paper

Kwang Woon Kim, Julia Y. Kim, Jingbo Qiao, Rachael A. Clark, Camille M. Powers, Hernan Correa, Dai H. Chung

Published Sep 5, 2019

Keywords: chemotherapy, radiotherapy, resistance, AKT2, MAPK

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma Correction

Akihiro Ohmoto, Masami Suzuki, Erina Takai, Hirofumi Rokutan, Yuko Fujiwara, Chigusa Morizane, Kazuyoshi Yanagihara, Tatsuhiro Shibata, Shinichi Yachida

Published Sep 4, 2019 · Vol. 10, No. 52 · pp. 5494-5494

Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapy Research Paper

Satoshi Tsunetoh, Yoshito Terai, Masaaki Takai, Satoe Fujiwara, Yoshimichi Tanaka, Tomohito Tanaka, Hiroshi Sasaki, Naokazu Ibuki, Takanobu Ubai, Kazuhiro Yamamoto, Haruhito Azuma, Masahide Ohmichi

Published Aug 27, 2019 · Vol. 10, No. 50 · pp. 5207-5216

Keywords: uterine cervical cancer, nerve-sparing radical hysterectomy (NSRH), urodynamic study, neoadjuvant chemotherapy, balloon-occluded arterial infusion (BOAI)

A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting Research Paper

Martin Boegemann, Katrin Schlack, Lena Früchtenicht, Julie Steinestel, Andres Jan Schrader, Yvonne Wennmann, Laura-Maria Krabbe, Okyaz Eminaga

Published Aug 20, 2019 · Vol. 10, No. 49 · pp. 5082-5091

Keywords: risk score, mCRPC, abiraterone, survival, outcome

Idiotypic and anti-idiotypic antibodies against polycyclic aromatic hydrocarbon in human blood serum are new biomarkers of lung cancer Research Paper

Ivan S. Grebenshchikov, Artem E. Studennikov, Vadim I. Ivanov, Natalia V. Ivanova, Victor A. Titov, Natalja E. Vergbickaya, Valentin A. Ustinov

Published Aug 20, 2019 · Vol. 10, No. 49 · pp. 5070-5081

Keywords: polycyclic aromatic hydrocarbon, benzo[a]pyrene, anti-idiotypic antibodies, idiotypic antibodies, lung cancer

Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins Research Paper

Manabu Sasada, Takuya Iyoda, Tatsufumi Asayama, Yusuke Suenaga, Shunsuke Sakai, Naoya Kase, Hiroaki Kodama, Sana Yokoi, Yoichiro Isohama, Fumio Fukai

Published Aug 13, 2019 · Vol. 10, No. 48 · pp. 4960-4972

Keywords: integrin, Myc, proteasomal degradation, fibronectin, neuroblastoma

Chemo-/immuno-/radiotherapy combination in treatment of solid cancer Editorial

Lukas Käsmann, Julian Taugner, Farkhad Manapov

Published Aug 2, 2019 · Vol. 10, No. 52 · pp. 5387-5388

Keywords: multimodal treatment, radiotherapy, immune checkpoint inhibition, chemotherapy, PD-1/PD-L1

Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancer Research Paper

Sebastian Prill, Jakob Rebstock, Anja Tennemann, Justus Körfer, Rasmus Sönnichsen, René Thieme, Ines Gockel, Orestis Lyros, Astrid Monecke, Christian Wittekind, Arved Weimann, Kerstin Grosser, Volker Wiechmann, Christoph Kubick, Ingo Bechmann, Florian Lordick, Sonja Kallendrusch

Published Jul 30, 2019 · Vol. 10, No. 46 · pp. 4731-4742

Keywords: tumor-associated macrophages, tumor slice cultures, deferoxamine, gastric cancer, iron

Genomics applied to the treatment of breast cancer Review

Diaddin Hamdan, Thi Thuy Nguyen, Christophe Leboeuf, Solveig Meles, Anne Janin, Guilhem Bousquet

Published Jul 30, 2019 · Vol. 10, No. 46 · pp. 4786-4801

Keywords: constitutional genomics, genomics applied to treatment, genomics of breast cancer, molecular and histological classification, tumor heterogeneity

Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes Editorial

Cestmir Altaner, Ursula Altanerova, Jana Jakubechova

Published Jul 27, 2019 · Vol. 10, No. 54 · pp. 5573-5575

Keywords: mesenchymal stem/stromal cells, exosome, suicide gene, yCD::UPRT, 5-fluorocytosine, 5-fluorouracil

Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response Research Paper

Alessia Garufi, Gianandrea Traversi, Maria Saveria Gilardini Montani, Valerio D’Orazi, Giuseppa Pistritto, Mara Cirone, Gabriella D’Orazi

Published Jul 23, 2019 · Vol. 10, No. 45 · pp. 4691-4702

Keywords: chemoresistance, reactive oxygen species (ROS), high glucose (HG), cancer, nuclear factor erythroid 2-related factor 2 (NRF2)

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo Research Paper

Elgilda Musi, Gary K. Schwartz, Jae Hyuk Yoo, Shannon J. Odelberg, Dean Y. Li, Michael Y. Bonner, Ponniah Selvakumar, Shikha Rao, Linda C. Gilbert, Justin Elsey, Jack L. Arbiser

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4424-4436

Keywords: melanoma, chemotherapy

Differential gene expression and AKT targeting in triple negative breast cancer Research Paper

Feng-Mao Lin, Susan E. Yost, Wei Wen, Paul H. Frankel, Daniel Schmolze, Pei-Guo Chu, Yate-Ching Yuan, Zheng Liu, John Yim, Zhen Chen, Yuan Yuan

Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4356-4368

Keywords: AKT, differential expression, AKT targeting, TNBC

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy Editorial

Stephen L. Luen, Roberto Salgado, Sherene Loi

Published Jul 4, 2019 · Vol. 10, No. 45 · pp. 4612-4614

Keywords: triple negative breast cancer, tumor infiltrating lymphocytes, neoadjuvant chemotherapy, prognosis

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval Research Paper

Eva Ciruelos, Emilio Alba, Rafael López, Anna Lluch, Miguel Martín, Isabel Arroyo, Beatriz Navarro, David Carcedo, Ramón Colomer, Joan Albanell

Published Jul 2, 2019 · Vol. 10, No. 42 · pp. 4321-4332

Keywords: early breast cancer, trastuzumab, life-years, economics, Spain

Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme Research Paper

Zafar Malik, Axel Heidenreich, Sergio Bracarda, Alexandros Ardavanis, Philip Parente, Hans-Joerg Scholz, Ayse Ozatilgan, Evelyne Ecstein-Fraisse, Simon Hitier, Giuseppe Di Lorenzo

Published Jun 25, 2019 · Vol. 10, No. 41 · pp. 4161-4168

Keywords: mCRPC, cabazitaxel, CUP, EAP, real-world

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy Research Paper

Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP Research Paper

Application of C. elegans cancer screening test for the detection of pancreatic tumor in genetically engineered mice Research Paper

SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells Research Paper

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma Research Paper

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma Correction

Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapy Research Paper

A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting Research Paper

Idiotypic and anti-idiotypic antibodies against polycyclic aromatic hydrocarbon in human blood serum are new biomarkers of lung cancer Research Paper

Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins Research Paper

Chemo-/immuno-/radiotherapy combination in treatment of solid cancer Editorial

Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancer Research Paper

Genomics applied to the treatment of breast cancer Review

Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes Editorial

Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response Research Paper

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo Research Paper

Differential gene expression and AKT targeting in triple negative breast cancer Research Paper

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy Editorial

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval Research Paper

Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy Research Paper

Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP Research Paper

Application of C. elegans cancer screening test for the detection of pancreatic tumor in genetically engineered mice Research Paper

SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells Research Paper

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma Research Paper

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma Correction

Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapy Research Paper

A prognostic score for overall survival in patients treated with abiraterone in the pre- and post-chemotherapy setting Research Paper

Idiotypic and anti-idiotypic antibodies against polycyclic aromatic hydrocarbon in human blood serum are new biomarkers of lung cancer Research Paper

Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins Research Paper

Chemo-/immuno-/radiotherapy combination in treatment of solid cancer Editorial

Tumor-associated macrophages and individual chemo-susceptibility are influenced by iron chelation in human slice cultures of gastric cancer Research Paper

Genomics applied to the treatment of breast cancer Review

Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes Editorial

Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response Research Paper

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo Research Paper

Differential gene expression and AKT targeting in triple negative breast cancer Research Paper

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy Editorial

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval Research Paper

Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme Research Paper